A detailed history of Biltmore Family Office, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Biltmore Family Office, LLC holds 53,623 shares of MRK stock, worth $6.64 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
53,623
Previous 53,623 -0.0%
Holding current value
$6.64 Million
Previous $5.85 Million 21.04%
% of portfolio
1.43%
Previous 1.21%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $33,961 - $36,957
339 Added 0.64%
53,623 $5.85 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $7,618 - $8,460
74 Added 0.14%
53,284 $5.49 Million
Q2 2023

Aug 07, 2023

BUY
$108.61 - $118.38 $3,584 - $3,906
33 Added 0.06%
53,210 $6.14 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $883,019 - $985,269
8,578 Added 19.23%
53,177 $5.66 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $8,918 - $11,435
102 Added 0.23%
44,599 $4.95 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $25,189 - $28,298
298 Added 0.67%
44,497 $3.86 Million
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $40,659 - $46,089
487 Added 1.11%
44,199 $4.06 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $276,324 - $309,741
-3,759 Reduced 7.92%
43,712 $3.62 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $292,372 - $366,234
4,045 Added 9.31%
47,471 $3.67 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $73,400 - $80,721
-1,024 Reduced 2.3%
43,426 $3.29 Million
Q2 2021

Jul 30, 2021

BUY
$70.31 - $77.77 $20,671 - $22,864
294 Added 0.67%
44,450 $3.49 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $9,089 - $10,706
132 Added 0.3%
44,156 $3.43 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $2.36 Million - $2.62 Million
32,934 Added 296.97%
44,024 $3.63 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $2,927 - $3,318
-40 Reduced 0.36%
11,090 $927,000
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $352 - $400
5 Added 0.04%
11,130 $867,000
Q1 2020

May 08, 2020

SELL
$63.36 - $87.82 $1.56 Million - $2.16 Million
-24,610 Reduced 68.87%
11,125 $863,000
Q4 2019

Feb 05, 2020

BUY
$77.58 - $87.54 $71,606 - $80,799
923 Added 2.65%
35,735 $3.27 Million
Q3 2019

Oct 16, 2019

BUY
$76.08 - $82.93 $936,696 - $1.02 Million
12,312 Added 54.72%
34,812 $2.95 Million
Q2 2019

Jul 31, 2019

SELL
$69.84 - $81.59 $48,818 - $57,031
-699 Reduced 3.01%
22,500 $1.9 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $105,819 - $122,801
1,622 Added 7.52%
23,199 $1.79 Million
Q3 2018

Oct 30, 2018

SELL
$57.69 - $67.84 $9,807 - $11,532
-170 Reduced 0.78%
21,577 $1.54 Million
Q2 2018

Jul 17, 2018

SELL
$50.83 - $59.72 $10,928 - $12,839
-215 Reduced 0.98%
21,747 $1.33 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $1.13 Million - $1.35 Million
21,962
21,962 $1.25 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Biltmore Family Office, LLC Portfolio

Follow Biltmore Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.